List of Tables
Table 1. Global Histone Deacetylase (HDAC) Inhibitors Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Histone Deacetylase (HDAC) Inhibitors Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Covered in This Study
Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers (2016-2021)
Table 7. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Histone Deacetylase (HDAC) Inhibitors Manufacturing Sites and Area Served
Table 11. Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Type
Table 12. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Histone Deacetylase (HDAC) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2016-2021) & (K MT)
Table 16. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2016-2021)
Table 17. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 19. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2016-2021)
Table 20. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2016-2021)
Table 22. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 23. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2016-2021)
Table 24. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2016-2021)
Table 30. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2016-2021)
Table 32. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2016-2021)
Table 38. Global Histone Deacetylase (HDAC) Inhibitors Sales (K MT) by Type (2016-2021)
Table 39. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2016-2021)
Table 40. Global Histone Deacetylase (HDAC) Inhibitors Revenue (Million US$) by Type (2016-2021)
Table 41. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2016-2021)
Table 42. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2016-2021)
Table 43. Global Histone Deacetylase (HDAC) Inhibitors Sales (K MT) by Application (2016-2021)
Table 44. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2016-2021)
Table 45. Global Histone Deacetylase (HDAC) Inhibitors Revenue (Million US$) by Application (2016-2021)
Table 46. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2016-2021)
Table 47. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2016-2021)
Table 48. 4SC Corporation Information
Table 49. 4SC Description and Business Overview
Table 50. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. 4SC Histone Deacetylase (HDAC) Inhibitors Product
Table 52. 4SC Recent Developments/Updates
Table 53. Acetylon Pharmaceuticals Corporation Information
Table 54. Acetylon Pharmaceuticals Description and Business Overview
Table 55. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product
Table 57. Acetylon Pharmaceuticals Recent Developments/Updates
Table 58. Celleron Therapeutics Corporation Information
Table 59. Celleron Therapeutics Description and Business Overview
Table 60. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 62. Celleron Therapeutics Recent Developments/Updates
Table 63. Chipscreen Biosciences Corporation Information
Table 64. Chipscreen Biosciences Description and Business Overview
Table 65. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product
Table 67. Chipscreen Biosciences Recent Developments/Updates
Table 68. Chroma Therapeutics Corporation Information
Table 69. Chroma Therapeutics Description and Business Overview
Table 70. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 72. Chroma Therapeutics Recent Developments/Updates
Table 73. CrystalGenomics Corporation Information
Table 74. CrystalGenomics Description and Business Overview
Table 75. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product
Table 77. CrystalGenomics Recent Developments/Updates
Table 78. Curis Corporation Information
Table 79. Curis Description and Business Overview
Table 80. Curis Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Curis Histone Deacetylase (HDAC) Inhibitors Product
Table 82. Curis Recent Developments/Updates
Table 83. MEI Pharma Corporation Information
Table 84. MEI Pharma Description and Business Overview
Table 85. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product
Table 87. MEI Pharma Recent Developments/Updates
Table 88. Mirati Therapeutics Corporation Information
Table 89. Mirati Therapeutics Description and Business Overview
Table 90. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
Table 92. Mirati Therapeutics Recent Developments/Updates
Table 93. Novartis Corporation Information
Table 94. Novartis Description and Business Overview
Table 95. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Novartis Histone Deacetylase (HDAC) Inhibitors Product
Table 97. Novartis Recent Developments/Updates
Table 98. Onxeo Corporation Information
Table 99. Onxeo Description and Business Overview
Table 100. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Onxeo Histone Deacetylase (HDAC) Inhibitors Product
Table 102. Onxeo Recent Developments/Updates
Table 103. Repligen Corporation Information
Table 104. Repligen Description and Business Overview
Table 105. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Repligen Histone Deacetylase (HDAC) Inhibitors Product
Table 107. Repligen Recent Developments/Updates
Table 108. TetraLogic Corporation Information
Table 109. TetraLogic Description and Business Overview
Table 110. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product
Table 112. TetraLogic Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Histone Deacetylase (HDAC) Inhibitors Distributors List
Table 116. Histone Deacetylase (HDAC) Inhibitors Customers List
Table 117. Histone Deacetylase (HDAC) Inhibitors Market Trends
Table 118. Histone Deacetylase (HDAC) Inhibitors Growth Drivers
Table 119. Histone Deacetylase (HDAC) Inhibitors Market Restraints
Table 120. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Type (2022-2027) & (K MT)
Table 121. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Application (2022-2027) & (K MT)
Table 125. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Region (2022-2027) & (K MT)
Table 129. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Histone Deacetylase (HDAC) Inhibitors
Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Type in 2020 & 2027
Figure 3. Fatty Acid Product Picture
Figure 4. Hydroxamate Product Picture
Figure 5. Cyclic Peptide Product Picture
Figure 6. Benzamide Product Picture
Figure 7. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Application in 2020 & 2027
Figure 8. Treatment of Malignant Tumors
Figure 9. Chronic Disease Treatment
Figure 10. Others
Figure 11. Global Histone Deacetylase (HDAC) Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Histone Deacetylase (HDAC) Inhibitors Market Size 2016-2027 (US$ Million)
Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Sales 2016-2027 (K MT)
Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers in 2020
Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players: Market Share by Revenue in 2020
Figure 18. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2016-2021)
Figure 20. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region in 2020
Figure 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2016-2021)
Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region in 2020
Figure 23. U.S. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2016-2021)
Figure 48. Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2016-2021)
Figure 49. Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Application in 2020
Figure 50. Revenue Share of Histone Deacetylase (HDAC) Inhibitors by Application (2016-2021)
Figure 51. Revenue Share of Histone Deacetylase (HDAC) Inhibitors by Application in 2020
Figure 52. Manufacturing Cost Structure of Histone Deacetylase (HDAC) Inhibitors
Figure 53. Manufacturing Process Analysis of Histone Deacetylase (HDAC) Inhibitors
Figure 54. Histone Deacetylase (HDAC) Inhibitors Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

LIST OF FIGURE